These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36181101)

  • 1. The clinical prognostic value of long noncoding RNA HAND2-AS1 in cancer patients: A study based on meta-analysis and TCGA data (PRISMA).
    Yan Z; Lu J; Xu X; You Y; Xu J; Xu T
    Medicine (Baltimore); 2022 Sep; 101(39):e30789. PubMed ID: 36181101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
    Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
    BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical prognostic value of lncRNA FOXP4-AS1 in cancer patients: A meta-analysis and bioinformatics analysis based on TCGA datasets.
    Shu Q; Liu X; Yang J; Mou T; Xie F
    Medicine (Baltimore); 2022 Oct; 101(42):e31439. PubMed ID: 36281152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of lncRNA AGAP2-AS1 in cancer patients: A meta-analysis.
    Zhong P; Hua H; Chen S; Zhu Z; Xie F
    Medicine (Baltimore); 2021 Dec; 100(51):e28425. PubMed ID: 34941192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis.
    Wang J; Zhong P; Hua H
    Technol Cancer Res Treat; 2021; 20():15330338211004915. PubMed ID: 33906548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers.
    Zhang C; Ren X; Liu Z; Tu C
    BMC Cancer; 2020 Sep; 20(1):879. PubMed ID: 32928135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of long non-coding RNA FOXD2-AS1 expression in patients with solid tumors.
    Zhou L; Li Z; Shao X; Yang B; Feng J; Xu L; Teng Y
    Pathol Res Pract; 2019 Sep; 215(9):152449. PubMed ID: 31378453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of lncRNA FEZF1 antisense RNA 1 over-expression in oncologic outcomes of patients with solid tumors.
    Zhang Y; Yang QX; Peng TT; Wang LJ; Xiao GL; Tang SB
    Medicine (Baltimore); 2019 Jun; 98(24):e15982. PubMed ID: 31192939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
    Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
    Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles.
    Zhang Y; Liang C; Zhang Y; Wang Z; Li R; Wei Z; Guo J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DLX6-AS1 as a potential molecular biomarker in the clinicopathology and prognosis of various cancers: a meta-analysis.
    Tian S; Liu J; Kong S; Peng L
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32785606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of long noncoding RNA TTN-AS1 in various malignancies.
    Lin G; Liu X; Cong C; Xu L
    Cancer Rep (Hoboken); 2023 Oct; 6(10):e1876. PubMed ID: 37528740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review.
    Zhang F; Chen X; Xi K; Qiu Z; Wang Y; Gui Y; Hou Y; Chen K; Zhang X
    Onco Targets Ther; 2018; 11():7827-7840. PubMed ID: 30464530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers: A systematic review and meta-analysis.
    Zhou X; Fan YH; Wang Y; Liu Y
    Medicine (Baltimore); 2019 Dec; 98(49):e18264. PubMed ID: 31804362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients: A Meta-analysis.
    Zhou X; Fan YH; Wang Y; Wang F; Liu Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15251. PubMed ID: 31027073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prognostic Value of lncRNA MCM3AP-AS1 on Clinical Outcomes in Various Cancers: A Meta- and Bioinformatics Analysis.
    Fu L; Zhang G; Wang Y; Lu T; Liu B; Jiao Y; Ma H; Ma S; Yang K; Cai H
    Dis Markers; 2022; 2022():4466776. PubMed ID: 35783010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA LOXL1-AS1 expression in cancer prognosis: A meta-analysis.
    Wang X; Chen Z; Zhou H; Liu W; Luo J
    Medicine (Baltimore); 2022 Dec; 101(52):e32436. PubMed ID: 36596047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic and clinicopathologic significance of long non-coding RNA opa-interacting protein 5-antisense RNA 1 in multiple human cancers.
    Ren X; He J; Qi L; Li S; Zhang C; Duan Z; Wang W; Tu C; Li Z
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):353-361. PubMed ID: 31899963
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the prognostic value of long non-coding RNA CASC15 in human solid tumors utilizing The Cancer Genome Atlas (TCGA) datasets and a meta-analysis.
    Chen W; Qian W; Nie J; Dai M
    Clin Exp Med; 2023 Feb; 23(1):65-78. PubMed ID: 35103883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis.
    Liang C; Liu J; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Sep; 484():91-98. PubMed ID: 29778540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.